COVID-19 Business Interruption
Craig D. Rosenbaum | June 11, 2020 | Personal Injury
Civil authorities across the country have ordered many businesses to close to the public, both large and small, due to the COVID-19 pandemic, and it is having enormous consequences for millions of Americans. Most business insurance policies include coverage for lost earnings due to government shutdowns. This coverage is typically called “Business Interruption” and “Civil… read more
Pursuing compensation after a motor vehicle accident in New York
Craig D. Rosenbaum | June 5, 2020 | Car Accidents in New York
As the most populous city in the country, New York City inevitably has thousands of car accidents each year. Fortunately, most of these car accidents are so-called “fender benders,” and those involved – drivers and passengers – are able to walk away with minor injuries, if they are injured at all. But, unfortunately, much more… read more
New app aims to prevent distracted driving
Craig D. Rosenbaum | May 19, 2020 | Car Accidents in New York
Commuting to and from work is just part of the daily routine for many workers in New York, especially for those who hold more than one job. While some commuters will take the subway or a taxi, others will choose to drive themselves to and from work. Motorists in a rush may try to multi-task… read more
Death of NYPD Officer Shines Light on Roadway Dangers
Craig D. Rosenbaum | May 14, 2020 | Motorcycle Accidents
Just last month a 34-year-old member of the NYPD was killed while riding his motorcycle to work. The fallen officer was struck by a speeding driver who may have been racing a second vehicle when the fatal accident occurred. Through the driver of the vehicle that struck the officer has been taken into custody, many… read more
Zantac Litigation Update
Craig D. Rosenbaum | May 6, 2020 | Defective Drugs
The popular heartburn medication Zantac (ranitidine) was recalled and taken off shelves in September of 2019 after the Food and Drug Administration announced that it had found the cancer-causing chemical N-nitrosodimethylamine (NDMA) in samples of Zantac. On February 6, 2020 the Judicial Panel for Multidistrict Litigation formed MDL No. 2924 in the federal court in… read more
Potential compensation for those injured by Roundup exposure
Craig D. Rosenbaum | May 4, 2020 | Products Liability
For the many farmworkers, landscapers, groundskeepers, and gardeners who used the herbicide ‘Roundup’ on a long-term basis, there may be an elevated risk of developing certain cancers. The idea of beginning a lawsuit against a major agrochemical company is a daunting prospect for those people in modest lines of work. Despite this apprehension, there are… read more
Understand your options in a potential wrongful death claim
Craig D. Rosenbaum | May 4, 2020 | Wrongful Death
Tragic accidents in New York City can result in the sudden and unexpected deaths of our loved ones. In the most populous city in the country, traffic accidents are a daily occurrence. While most motor vehicle accidents are simple “fender benders,” others are fatal. Likewise, when New York residents receive medical treatment, they don’t anticipate… read more
Is New York City doing enough to curb dooring accidents?
Craig D. Rosenbaum | May 4, 2020 | Bicycle Accidents
Do you bike as part of your commute? If so, then there’s a pretty good chance that the thought of being involved in an accident had crossed your mind, even before one took you by surprise. Although bicycling is extraordinarily common in New York City and its suburbs, the fact remains that it is an… read more
Falls at the Grocery Store: What Victims Should Know
Craig D. Rosenbaum | April 22, 2020 | Premises Liability
Slip and fall injuries can happen anywhere, even in seemingly safe locations like grocery stores. From broken food containers that leave slick substances on floors to damp aisles from rain-soaked customers and workers, a variety of different events can result in unsafe conditions in New York markets and grocery centers. When a person is injured… read more
Zantac Recall-FDA Update
Craig D. Rosenbaum | April 7, 2020 | Defective Drugs
New FDA Announcement Calls for Zantac to be Pulled from Market The popular heartburn medication Zantac (ranitidine) was recalled and taken off shelves in September of 2019 after the Food and Drug Administration announced that it had found the cancer-causing chemical N-nitrosodimethylamine (NDMA) in samples of Zantac. The FDA has recently taken further action, announcing… read more